Denmark-based Lundbeck may soon sign a new acquisition agreement, after taking over Prexton Therapeutics two months ago for $905m.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,